CONMED Corporation (CNMD)
Largest Insider Buys in Sector
CNMD Stock Price History Chart
CNMD Stock Performance
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The …
Insider Activity of CONMED Corporation
Over the last 12 months, insiders at CONMED Corporation have bought $544,054 and sold $287,280 worth of CONMED Corporation stock.
On average, over the past 5 years, insiders at CONMED Corporation have bought $461,291 and sold $19.06M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Aronson Martha Goldberg (director) — $283,920. Beyer Pat (Chief Operating Officer) — $204,900. Schwarzentraub Barbara J (director) — $99,873.
The last purchase of 1,350 shares for transaction amount of $97,322 was made by BRONSON DAVID M (director) on 2024‑05‑13.
List of Insider Buy and Sell Transactions, CONMED Corporation
| 2024-06-14 | Sale | President AS and AET | 4,000 0.0125% | $71.82 | $287,280 | +0.07% | ||
| 2024-05-13 | director | 1,350 0.0043% | $72.09 | $97,322 | -0.80% | |||
| 2024-05-08 | director | 1,442 0.0047% | $69.26 | $99,873 | +4.08% | |||
| 2024-05-06 | director | 2,000 0.0065% | $70.98 | $141,960 | +1.82% | |||
| 2024-04-30 | Chief Operating Officer | 3,000 0.0098% | $68.30 | $204,900 | +5.80% | |||
| 2023-12-04 | Sale | President AS and AET | 2,300 0.0074% | $109.93 | $252,833 | -32.59% | ||
| 2023-11-07 | Sale | President AS and AET | 1,200 0.004% | $102.39 | $122,874 | -24.61% | ||
| 2023-09-13 | Sale | President AS and AET | 2,000 0.0065% | $107.31 | $214,629 | -24.30% | ||
| 2023-08-16 | Sale | Executive Vice President & CFO | 1,355 0.0045% | $112.00 | $151,760 | -20.67% | ||
| 2023-06-15 | Sale | President, CEO and Chair | 1,000 0.0033% | $136.00 | $136,000 | -27.06% | ||
| 2023-06-08 | Sale | Executive Vice President - HR | 1,700 0.0056% | $131.81 | $224,077 | -23.53% | ||
| 2023-06-08 | Sale | VP GM Advanced Surgery | 5,000 0.0163% | $131.14 | $655,676 | -23.53% | ||
| 2023-06-07 | Sale | director | 812 0.0027% | $129.01 | $104,756 | -21.15% | ||
| 2023-05-22 | Sale | VP GM Advanced Surgery | 1,500 0.0049% | $120.89 | $181,343 | -13.77% | ||
| 2023-05-18 | Sale | VP GM Advanced Surgery | 1,500 0.0049% | $119.24 | $178,861 | -10.93% | ||
| 2023-05-01 | Sale | director | 2,072 0.0067% | $125.00 | $259,000 | -14.52% | ||
| 2023-04-28 | Sale | Treasurer and VP, Tax | 8,717 0.0288% | $126.53 | $1.1M | -14.28% | ||
| 2023-04-28 | Sale | Special Counsel & Corp Secy | 10,000 0.0329% | $126.10 | $1.26M | -14.28% | ||
| 2023-04-28 | Sale | EVP, STRAT & CORP DEVT | 2,442 0.0082% | $128.00 | $312,576 | -14.28% | ||
| 2023-04-28 | Sale | Treasurer and VP, Tax | 24,017 0.0792% | $126.38 | $3.04M | -14.28% |
Insider Historical Profitability
| BRONSON DAVID M | director | 16460 0.0533% | $69.91 | 2 | 0 | <0.0001% |
| Beyer Pat | Chief Operating Officer | 10807 0.035% | $69.91 | 2 | 2 | <0.0001% |
| Aronson Martha Goldberg | director | 2000 0.0065% | $69.91 | 1 | 0 | |
| Schwarzentraub Barbara J | director | 1442 0.0047% | $69.91 | 1 | 1 | |
| SHALLISH ROBERT D JR | EVP, Finance, CFO | 53915 0.1745% | $69.91 | 2 | 12 | +8.79% |
Institutional Investor Ownership
| BlackRock | $409.65M | 16.61 | 5.12M | +1.68% | +$6.77M | 0.01 | |
| The Vanguard Group | $276.82M | 11.22 | 3.46M | +1.08% | +$2.95M | 0.01 | |
| EARNEST Partners | $189.88M | 7.7 | 2.37M | +1.08% | +$2.03M | 0.87 | |
| Capital Research Global Investors | $116.98M | 4.74 | 1.46M | -47.02% | -$103.81M | 0.03 | |
| Champlain Investment Partners, LLC | $104.35M | 4.23 | 1.3M | +36.12% | +$27.69M | 0.6 |